|
|
Hälsovägen 7
Huddinge, 141 57 Sweden
phone:08-449 84 80
fax:08-449 84 81
|
|
| Symbol |
TPEP |
| Exchange |
STO |
| Founded |
0 |
| Employees |
|
|
|
| www.tripep.se
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Drugs for AIDS and cancer based on patented technologies. |
|
| Management |
| Jan Nilsson, Chief Executive Officer; Anders Vahlne M.D. Ph.D., Vice President Head of Research and Director; Asa Ekstrand, Chief Financial Officer |
| |
|
|
|
|
|
|
|
| Keywords |
| drugs, aids, cancer, hiv, inhibiting, hepatitis, gpg, inhibitors, HIVAIDS |
|
|
|
| Description |
|
Tripep is a biotechnology research company engaged in the development and commercialization of candidate drugs for AIDS and cancer based on patented technologies. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
